AHA Coding Clinic® for HCPCS - 2017 Issue 4; For Your Information

A new modifier for a biosimilar biological product

A new modifier effective on July 1, 2017, and can be appended to HCPCS code Q5102, Injection, infliximab, biosimilar, 10 mg, for the biosimilar biological product utilized.  Therefore, as of July 1, 2017, there are now two existing modifiers that may be appended as applicable. See table on the following page. HCPCS Modifier Long Descriptor Effective Date HCPCS Code Long Descriptor ZB Pfizer/Hospira 04/01/2016 Q5102 Injection, Infliximab, Bio similar, 10 mg ZC Merck/Samsung Bioepis 07/1/2017 Q5102 Injection, Infliximab, Biosimilar, 10 mg ...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.

Thank you for choosing Find-A-Code, please Sign In to remove ads.